Aktuellt
SENASTE
Redeye updates on EG7 following the weaker-than-expected Q2-results which looks to be related to a continued soft performance in Toadman. The company has accelerated cost cuts and reiterated its guidance for the full year. As such, Redeye make limited changes to estimates and our valuation range is unchanged.
LÄS MER
